tirzepatide data shows 47% greater weight loss vs. Wegovy Is Tirzepatide Safe For Long-Term

Although typically prescribed in the outpatient setting, initiating glucagon-like peptide-one receptor agonists (GLP-1RAs) in the inpatient setting can be efficacious in reducing weight and increasing functional status

Benefit of semaglutide vs placebo additionally supported by statistically significant improvement in liver stiffness measurement by VCTE (FibroScan Echosens)

Learn what the latest evidence reveals.

Less common side effects (may affect up to 1 in 100 people)

Reddys Laboratories is all set to launch a generic version of Novo Nordisks semaglutide in India this March right after patent expiry with rollouts planned for other emerging markets and Canada soon after